RedHill Biopharma Ltd. (RDHL)

6.26
0.05 0.81
NASDAQ : Health Technology
Prev Close 6.21
Open 6.10
Day Low/High 6.08 / 6.39
52 Wk Low/High 4.30 / 11.25
Volume 90.98K
Avg Volume 131.20K
Exchange NASDAQ
Shares Outstanding 21.27M
Market Cap 122.07M
EPS -2.30
P/E Ratio 32.68
Div & Yield N.A. (N.A)

Latest News

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

The Summit, N.J.-based firm said Thursday that it was discontinuing the GED-0301 (mongersen) Phase 3 Revolve study in Crohn's disease and the extension trial.

Biotech Movers: Red Hill Jumps After Securing Rights Sell GERD Treatment

Biotech Movers: Red Hill Jumps After Securing Rights Sell GERD Treatment

A number of biotech-related stocks were down pre-market after announcing plans for public offerings.

TheStreet Quant Rating: D- (Sell)